PFG Investments’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

PFG Investments’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.91M	Sell	12,078 -1,581	-12%	-$214K	0.07%	233
2026 Q1	$1.74M	Sell	13,659 -745	-5%	-$93K	0.08%	220
2025 Q4	$1.76M	Buy	14,404 +1,241	+9%	+$142K	0.08%	211
2025 Q3	$1.32M	Sell	13,163 -199	-1%	-$17.9K	0.07%	261
2025 Q2	$1.11M	Sell	13,362 -1,337	-9%	-$107K	0.07%	281
2025 Q1	$1.19M	Sell	14,699 -641	-4%	-$57.3K	0.08%	259
2024 Q4	$1.38M	Sell	15,340 -6,045	-28%	-$586K	0.09%	221
2024 Q3	$2.11M	Sell	21,385 -3,459	-14%	-$340K	0.14%	145
2024 Q2	$2.3M	Buy	24,844 +2,097	+9%	+$188K	0.16%	118
2024 Q1	$2.16M	Buy	22,747 +16,021	+238%	+$1.49M	0.13%	175
2023 Q4	$601K	Sell	6,726 -1,840	-21%	-$137K	0.11%	207
2023 Q3	$625K	Sell	8,566 -615	-7%	-$49.1K	0.12%	191
2023 Q2	$764K	Buy	9,181 +3,848	+72%	+$322K	0.14%	164
2023 Q1	$406K	Buy	+5,333	New	+$442K	0.08%	276

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

JFG

Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

PFG Investments's XBI Position: Q2 2026 in Review

PFG Investments reduced its State Street SPDR S&P Biotech ETF (XBI) stake by 12% in Q2 2026, selling an estimated $214K and leaving 12,078 shares worth $1.91M. The position accounts for 0.07% of the portfolio, ranked #233.

PFG Investments first reported a position in XBI in Q1 2023 and has held it in 14 quarters since. The position peaked at $2.3M in Q2 2024. 932 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

PFG Investments held 12,078 shares of State Street SPDR S&P Biotech ETF worth $1.91M as of Q2 2026.
PFG Investments sold 1,581 State Street SPDR S&P Biotech ETF shares in Q2 2026, an estimated $214K.
State Street SPDR S&P Biotech ETF made up 0.07% of PFG Investments's portfolio in Q2 2026, its #233 holding.
PFG Investments first reported a position in State Street SPDR S&P Biotech ETF in Q1 2023 and has held it in 14 quarters since.
PFG Investments's State Street SPDR S&P Biotech ETF position peaked at $2.3M in Q2 2024.
932 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on PFG Investments's 13F filing for Q2 2026, filed 23 Jul 2026.